Trial Site Detail
Drug: |
IDRX-42 |
|||
|---|---|---|---|---|
Trial: |
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy (StrateGIST 3) |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Recruiting |
|||
University of Miami, Sylvester Comprehensive Cancer Center1475 Northwest 12th Ave 1st Floor |
Principal Investigator: |
Jonathan C. Trent |
|---|---|
Contact: |
JTrent@med.miami.edu 305-243-0180 Trials matching: 305-243-2647 |
Activation Status of this Site: |
Active |
Notes about this Site: |
|
University of Miami, Sylvester Comprehensive Cancer Center Website: |
http://uhealthsystem.com/clinical-trials/browse-clinical-trials/results?tarea=Bone%20and%20Soft%20Tissue%20Cancers&division=Cancer%20Center |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.